🇳🇱 Netherlands Country × Condition
pancreatic cancer Clinical Trials in Netherlands
Active clinical trials for pancreatic cancer with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 4 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇳🇱 Netherlands
Active Trials in Netherlands (3)
NCT05784311 Phase 4
Recruiting
Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW)
Enrollment
344 pts
Country
🇳🇱 Netherlands
Leiden University Medical Center
View Trial → NCT04075305
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Enrollment
8,000 pts
Country
🇳🇱 Netherlands
UMC Utrecht
View Trial → NCT05298722
Recruiting
Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)
Enrollment
45 pts
Country
🇳🇱 Netherlands
University Hospital, Ghent
View Trial → Frequently Asked Questions
How many pancreatic cancer clinical trials are active in Netherlands?
There are currently 3 active clinical trials for pancreatic cancer with sites in Netherlands, of which 3 are actively recruiting patients.
How can I join a pancreatic cancer clinical trial in Netherlands?
To join a pancreatic cancer clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are pancreatic cancer trials in Netherlands?
Active pancreatic cancer trials in Netherlands span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology